Among the 4400 patients who met the analysis criteria, the important characteristics (age, T stage, N stage, chemotherapy, systemic/surgery sequence, breast cancer type (triple negative or non‐triple negative), ER status, PR status, HER2 status, histological grade, and histological type) of the two groups were well matched (Table 1). This evidence concerns the gene ERBB2 and breast cancer.